Comparison between Clinitech Laboratory IPO and Manglam Infra IPO.
Clinitech Laboratory IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Manglam Infra IPO is a SME Bookbuilding proposed to list at NSE SME.
| Clinitech Laboratory IPO | Manglam Infra IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Inventure Merchant Banker Services Pvt.Ltd. | Unistone Capital Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Svcm Securities Pvt.Ltd. | Giriraj Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Clinitech Laboratory IPO is up to ₹5.48 Cr whereas the issue size of the Manglam Infra IPO is up to ₹24.70 Cr. The final issue price of Clinitech Laboratory IPO is ₹96.00 per share and of Manglam Infra IPO is ₹56.00 per share.
| Clinitech Laboratory IPO | Manglam Infra IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹53.00 per share | |
| Issue Price (Upper) | ₹56.00 per share | |
| Issue Price (Final) | ₹96.00 per share | ₹56.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 2000 shares |
| Fresh Issue Size | 5,71,200 shares | 44,10,000 shares |
| Fresh Issue Size (Amount) | up to ₹5.48 Cr | up to ₹24.70 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 5,71,200 shares | 44,10,000 shares |
| Issue Size Total (Amount) | up to ₹5.48 Cr | up to ₹24.70 Cr |
Clinitech Laboratory IPO opens on Jul 25, 2024, while Manglam Infra IPO opens on Jul 24, 2024. The closing date of Clinitech Laboratory IPO and Manglam Infra IPO is Jul 29, 2024, and Jul 26, 2024, respectively.
| Clinitech Laboratory IPO | Manglam Infra IPO | |
|---|---|---|
| Anchor Bid Date | Jul 23, 2024 | |
| Issue Open | Jul 25, 2024 | Jul 24, 2024 |
| Issue Close | Jul 29, 2024 | Jul 26, 2024 |
| Basis Of Allotment (Tentative) | Jul 30, 2024 | Jul 29, 2024 |
| Initiation of Refunds (Tentative) | Jul 31, 2024 | Jul 30, 2024 |
| Credit of Share (Tentative) | Jul 31, 2024 | Jul 30, 2024 |
| Listing date (Tentative) | Aug 01, 2024 | Jul 31, 2024 |
| Anchor Lockin End date 1 | Aug 28, 2024 | |
| Anchor Lockin End date 2 | Oct 27, 2024 |
Clinitech Laboratory IPO P/E ratio is 43.45, as compared to Manglam Infra IPO P/E ratio of 10.49.
| Clinitech Laboratory IPO | Manglam Infra IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Clinitech Laboratory Limited Financial Information (Restated)Clinitech Laboratory Limited's revenue increased by 1.19% and profit after tax (PAT) dropped by -39.46% between the financial year ending with March 31, 2024 and March 31, 2023.
| Manglam Infra and Engineering Limited Financial Information (Restated)Manglam Infra and Engineering Limited's revenue increased by 16.46% and profit after tax (PAT) rose by 22.06% between the financial year ending with March 31, 2024 and March 31, 2023.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 83.63 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 61.56 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 43.45 | 10.49 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹21.91 Cr. | ₹98.54 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 49.44% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 44.95% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.24 | 0.26 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.21 | ₹5.34 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 10.46% | 49.44% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Clinitech Laboratory IPO Retail Individual Investors (RII) are offered 2,85,600 shares while in Manglam Infra IPO retail investors are offered 2,85,600 shares. Qualified Institutional Buyers (QIB) are offered in Clinitech Laboratory IPO and 8,82,000 shares in Manglam Infra IPO.
| Clinitech Laboratory IPO | Manglam Infra IPO | |
|---|---|---|
| Anchor Investor Reserveration | 13,22,000 shares | |
| Market Maker Reserveration | 31,200 shares | 5,22,000 shares |
| QIB | 8,82,000 shares | |
| NII | 2,85,600 shares | 6,62,000 shares |
| RII | 2,85,600 shares | 15,44,000 shares |
| Employee | ||
| Others | ||
| Total | 5,71,200 shares | 44,10,000 shares |
Clinitech Laboratory IPO subscribed 38.96x in total, whereas Manglam Infra IPO subscribed 394.42x.
| Clinitech Laboratory IPO | Manglam Infra IPO | |
|---|---|---|
| QIB (times) | 163.04x | |
| NII (times) | 23.28x | 756.73x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 49.61x | 371.72x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 38.96x | 394.42x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
